Skip to main content
Clinical Trials/NCT01984476
NCT01984476
Completed
N/A

Impact of Age on Cardiovascular, Cerebrovascular and Cognitive Health in Spinal Cord Injury

James J. Peters Veterans Affairs Medical Center1 site in 1 country120 target enrollmentJuly 2013

Overview

Phase
N/A
Intervention
Not specified
Conditions
Spinal Cord Injury
Sponsor
James J. Peters Veterans Affairs Medical Center
Enrollment
120
Locations
1
Primary Endpoint
Arterial Stiffness
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

As the spinal cord injured population ages, these individuals are being exposed to an increased prevalence of age-associated diseases, which coupled with the secondary complications of the injury may contribute to the reduced life expectancies. Decentralized autonomic regulation in persons with SCI results in a multitude of cardiovascular changes, which may contribute to accelerated aging. Adverse cardiovascular changes may have deleterious effects on cerebral blood flow dynamics and an increase in cerebral vascular resistance index in individuals with SCI during cognitive testing. Deficits in memory and processing speed in individuals with SCI may relate to cardiovascular and cerebrovascular dysfunction. Identifying the associations between healthy aging versus premature or accelerated aging in organ system function in the SCI population is an important first step towards prevention and amelioration of these changes. Therefore the study objectives are to compare, among individuals with SCI, age-matched non-SCI and older non-SCI individuals arterial stiffness and cerebral vascular resistance index; memory, processing speed, and executive function; and volume of white matter hyperintensities. 60 individuals with SCI, 30 age-matched non-SCI controls, and 20 older non-SCI controls will be recruited for this study. All potential subjects will undergo a two-part screening process which consists of an initial screening via telephone and a detailed, in-person screening. Eligible subjects will be invited to participate in a 4 hour laboratory visit during which their arterial stiffness, blood pressure, heart rate, respiration rate and, blood flow to the brain will be monitored at rest and during a comprehensive series of cognitive tests. A subset of the participants will be asked to take part in an MRI brain imaging session: 40 persons with SCI, 10 age-matched non-SCI and 10 older non-SCI. Eligible subjects will be asked to participate in a 1 hour MRI/functional magnetic resonance imaging(fMRI) session.

We hypothesize that arterial stiffness and cerebral vascular resistance index will be increased in the SCI group compared to the age-matched non-SCI but will be comparable to the older non-SCI groups. In addition, we hypothesize that the prevalence of mild to moderate cognitive impairments in memory, processing speed, and executive function will be increased in the SCI individuals compared to the age-matched non-SCI but will be comparable to the older non-SCI individuals.

Detailed Description

The cognitive test battery will consists of the tests listed below, administered in the order given. 1. Digit Span 2. California Verbal Learning Test 3. Symbol Digit Modalities Test 4. Letter Number Sequencing 5. California Verbal Learning Test Delay 6. Paced Auditory Serial Addition Test 7. D-KEFS Verbal Fluency 8. D-KEFS Color-Word 9. WASI Vocabulary 10. WASI Matrix Reasoning

Registry
clinicaltrials.gov
Start Date
July 2013
End Date
July 2017
Last Updated
8 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
James J. Peters Veterans Affairs Medical Center
Responsible Party
Principal Investigator
Principal Investigator

Jill M. Wecht, Ed.D.

Research Health Scientist

James J. Peters Veterans Affairs Medical Center

Eligibility Criteria

Inclusion Criteria

  • Between the ages of 25 and 49 years old
  • Duration of injury must be between 5 and 10 years
  • AIS grade of A or B
  • Non-ambulatory (wheelchair dependent)
  • At least 20/60 minimum acuity in worst eye on the Snell Eye Exam
  • A score ≥24 on the Montreal Cognitive Assessment
  • English literate
  • Able to provide informed consent
  • Age-matched non-SCI
  • Between the ages of 25 and 49 years old

Exclusion Criteria

  • Acute illness or infection
  • Documented history of:
  • Controlled or uncontrolled hypertension or Diabetes mellitus
  • Recent illicit drug abuse (from medical chart, within the past 6-months)
  • Epilepsy or seizures
  • Neurodegenerative disease including Alzheimer's disease, Parkinson's disease, Dementia, Stroke, Multiple sclerosis
  • Severe TBI (identified by TBI screening tool)
  • Any significant history of psychiatric disease/disorders:
  • Post-traumatic stress disorder
  • schizophrenia

Outcomes

Primary Outcomes

Arterial Stiffness

Time Frame: Up to 2 years

To determine the difference in arterial stiffness among individuals with SCI to age-matched non-SCI and older non-SCI.

Cerebral Vascular Resistance Index

Time Frame: Up to 2 years

To determine the difference in cerebral vascular resistance index among individuals with SCI to age-matched non-SCI and older non-SCI.

Secondary Outcomes

  • Performance on Cognition Battery Tests(Up to 2 years)

Study Sites (1)

Loading locations...

Similar Trials